The bile acid-phospholipid conjugate ursodeoxycholyl-lysophosphatidylethanolamide (UDCA-LPE) disintegrates the lipid backbone of raft plasma membrane domains by the removal of the membrane phospholipase A2

The bile acid-phospholipid conjugate ursodeoxycholyl-lysophosphatidylethanolamide (UDCA-LPE) was shown to have anti-inflammatory, antisteatotic, and antifibrotic properties, rendering it as a drug targeting non-alcoholic steatohepatitis (NASH). On a molecular level, it disrupted the heterotetrameric...

Full description

Saved in:
Bibliographic Details
Main Authors: Stremmel, Wolfgang (Author) , Staffer, Simone (Author) , Fricker, Gert (Author) , Weiskirchen, Ralf (Author)
Format: Article (Journal)
Language:English
Published: 11 November 2019
In: International journal of molecular sciences
Year: 2019, Volume: 20, Issue: 22, Pages: 5631
ISSN:1422-0067
DOI:10.3390/ijms20225631
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/ijms20225631
Verlag, kostenfrei, Volltext: https://www.mdpi.com/1422-0067/20/22/5631
Verlag, kostenfrei, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888454
Get full text
Author Notes:Wolfgang Stremmel, Simone Staffer, Gert Fricker, Ralf Weiskirchen
Description
Summary:The bile acid-phospholipid conjugate ursodeoxycholyl-lysophosphatidylethanolamide (UDCA-LPE) was shown to have anti-inflammatory, antisteatotic, and antifibrotic properties, rendering it as a drug targeting non-alcoholic steatohepatitis (NASH). On a molecular level, it disrupted the heterotetrameric fatty acid uptake complex localized in detergent-resistant membrane domains of the plasma membrane (DRM-PM). However, its mode of action was unclear. Methodologically, UDCA-LPE was incubated with the liver tumor cell line HepG2 as well as their isolated DRM-PM and all other cellular membranes (non-DRM). The membrane cholesterol and phospholipids were quantified as well as the DRM-PM protein composition by Western blotting. The results show a loss of DRM-PM by UDCA-LPE (50 µM) with a 63.13 ± 7.14% reduction of phospholipids and an 81.94 ± 8.30% reduction of cholesterol in relation to mg total protein. The ratio of phospholipids to cholesterol changed from 2:1 to 4:1, resembling those of non-DRM fractions. Among the members of the fatty acid uptake complex, the calcium-independent membrane phospholipase A2 (iPLA2β) abandoned DRM-PM most rapidly. As a consequence, the other members of this transport system disappeared as well as the DRM-PM anchored fibrosis regulating proteins integrin β-1 and lysophospholipid receptor 1 (LPAR-1). It is concluded that UDCA-LPE executes its action by iPLA2β removal from DRM-PM and consequent dissolution of the raft lipid platform.
Item Description:Gesehen am 14.04.2020
Physical Description:Online Resource
ISSN:1422-0067
DOI:10.3390/ijms20225631